Prudential Financial’s Mustang Bio MBIO Stock Holding History

Prudential Financial’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14	Closed	-$29K	–	2669
2021 Q3	$29K	Sell	14 -3	-18%	-$6.44K	﹤0.01%	2570
2021 Q2	$42K	Buy	+17	New	+$41.7K	﹤0.01%	2523

Other funds holding MBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Prudential Financial's MBIO Position: Q4 2021 in Review

Prudential Financial sold out of Mustang Bio (MBIO) in Q4 2021, closing a stake of 14 shares — an estimated $29K sold.

Prudential Financial first reported a position in MBIO in Q2 2021 and held it in 2 quarters. The position peaked at $42K in Q2 2021. 83 funds tracked by Wall St. Rank hold MBIO as of Q4 2021.

Prudential Financial reported no remaining Mustang Bio position as of Q4 2021 after selling out during the quarter.
Prudential Financial sold 14 Mustang Bio shares in Q4 2021, an estimated $29K.
Prudential Financial first reported a position in Mustang Bio in Q2 2021 and held it in 2 quarters.
Prudential Financial's Mustang Bio position peaked at $42K in Q2 2021.
83 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2021.

Based on Prudential Financial's 13F filing for Q4 2021, filed 14 Feb 2022.